SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-13
DOI
10.1038/s41467-019-14138-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deficiency of both farnesoid X receptor and Takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice
- (2019) Jessica M. Ferrell et al. HEPATOLOGY
- Nuclear lipid droplets derive from a lipoprotein precursor and regulate phosphatidylcholine synthesis
- (2019) Kamil Sołtysik et al. Nature Communications
- Lack of androgen receptor SUMOylation results in male infertility due to epididymal dysfunction
- (2019) Fu-Ping Zhang et al. Nature Communications
- FXR Regulates Intestinal Cancer Stem Cell Proliferation
- (2019) Ting Fu et al. CELL
- Molecular tuning of farnesoid X receptor partial agonism
- (2019) Daniel Merk et al. Nature Communications
- Obeticholic acid: towards first approval for NASH
- (2019) Mohammed Eslam et al. LANCET
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- Novel perspectives in the management of decompensated cirrhosis
- (2018) Mauro Bernardi et al. Nature Reviews Gastroenterology & Hepatology
- Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
- (2018) Sangwon Byun et al. Nature Communications
- Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
- (2018) Pushpa Hegde et al. Nature Communications
- A giant amphipathic helix from a perilipin that is adapted for coating lipid droplets
- (2018) Alenka Čopič et al. Nature Communications
- FXR modulators for enterohepatic and metabolic diseases
- (2018) Hong Wang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Apoptosis and necroptosis in the liver: a matter of life and death
- (2018) Robert F. Schwabe et al. Nature Reviews Gastroenterology & Hepatology
- Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis
- (2018) Hong Wang et al. EBioMedicine
- Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
- (2018) Jiyu Zhou et al. Acta Pharmaceutica Sinica B
- The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
- (2017) Francesca Virginia Bruschi et al. HEPATOLOGY
- Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis
- (2017) Sumeyye Samur et al. HEPATOLOGY
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
- (2017) Philipp Schwabl et al. JOURNAL OF HEPATOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- A CK2–RNF4 interplay coordinates non-canonical SUMOylation and degradation of nuclear receptor FXR
- (2017) Stéphanie Bilodeau et al. Journal of Molecular Cell Biology
- Site-specific identification and quantitation of endogenous SUMO modifications under native conditions
- (2017) Ryan J. Lumpkin et al. Nature Communications
- The Perilipins: Major Cytosolic Lipid Droplet–Associated Proteins and Their Roles in Cellular Lipid Storage, Mobilization, and Systemic Homeostasis
- (2016) Alan R. Kimmel et al. Annual Review of Nutrition
- Bile Acid Analog Intercepts Liver Fibrosis
- (2016) C. Daniel De Magalhaes Filho et al. CELL
- Liver Capsule: FXR agonists against liver disease
- (2016) Claudia D. Fuchs et al. HEPATOLOGY
- Crucial steps towards an effective treatment
- (2016) Klaas Poelstra Nature Reviews Gastroenterology & Hepatology
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Fat: Mechanisms of Protein Localization to Lipid Droplets
- (2016) Nora Kory et al. TRENDS IN CELL BIOLOGY
- Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
- (2016) Natalia Gomez-Ospina et al. Nature Communications
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Thioesterase superfamily member 1 suppresses cold thermogenesis by limiting the oxidation of lipid droplet-derived fatty acids in brown adipose tissue
- (2016) Kosuke Okada et al. Molecular Metabolism
- Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming
- (2016) Yang Xie et al. Scientific Reports
- Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein
- (2015) Fiona O'Mahony et al. HEPATOLOGY
- Hepatic fibrosis: Concept to treatment
- (2015) Christian Trautwein et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis
- (2015) Susmita Kaushik et al. NATURE CELL BIOLOGY
- Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections
- (2015) David F. Bruhn et al. Science Translational Medicine
- A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
- (2014) D.-H. Kim et al. EMBO JOURNAL
- Transcriptional regulation of autophagy by an FXR–CREB axis
- (2014) Sunmi Seok et al. NATURE
- Nutrient-sensing nuclear receptors coordinate autophagy
- (2014) Jae Man Lee et al. NATURE
- Spectomycin B1 as a Novel SUMOylation Inhibitor That Directly Binds to SUMO E2
- (2013) Mikako Hirohama et al. ACS Chemical Biology
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease
- (2013) Anping Chen et al. HEPATOLOGY
- Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
- (2013) Len Verbeke et al. HEPATOLOGY
- SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes
- (2013) Natarajan Balasubramaniyan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Perilipin discerns chronic from acute hepatocellular steatosis
- (2013) Lena Maria Pawella et al. JOURNAL OF HEPATOLOGY
- Perilipin1 promotes unilocular lipid droplet formation through the activation of Fsp27 in adipocytes
- (2013) Zhiqi Sun et al. Nature Communications
- Roles of microRNA-29a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells
- (2011) J. Li et al. MOLECULAR PHARMACOLOGY
- Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate
- (2009) Isao Fukuda et al. CHEMISTRY & BIOLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- FXR: a metabolic regulator and cell protector
- (2008) Yan-Dong Wang et al. CELL RESEARCH
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started